STERIS CORP 4
4 · STERIS CORP · Filed Nov 2, 2015
Insider Transaction Report
Form 4
STERIS CORPSTE
WAREHAM JOHN P
Director
Transactions
- Disposition to Issuer
Director Stock Option (right to buy)
2015-11-02−4,995→ 0 totalExercise: $31.61Exp: 2021-08-03→ Common Shares, No Par Value (4,995 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2015-11-02−5,936→ 0 totalExercise: $64.05Exp: 2025-08-31→ Common Shares, No Par Value (5,936 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2015-11-02−6,727→ 0 totalExercise: $43.92Exp: 2023-08-08→ Common Shares, No Par Value (6,727 underlying) - Disposition to Issuer
Career Restricted Stock Units
2015-11-02−5,633→ 0 total→ Common Shares, No Par Value (5,633 underlying) - Disposition to Issuer
Common Shares, No Par Value
2015-11-02−31,560→ 0 total - Disposition to Issuer
Director Stock Option (right to buy)
2015-11-02−5,150→ 0 totalExercise: $32.36Exp: 2022-08-03→ Common Shares, No Par Value (5,150 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2015-11-02−6,622→ 0 totalExercise: $51.53Exp: 2024-08-06→ Common Shares, No Par Value (6,622 underlying)
Footnotes (7)
- [F1]Represents shares of STERIS Corporation ("STERIS") disposed of pursuant to merger of a wholly-owned subsidiary of STERIS plc ("New STERIS") with and into STERIS, with STERIS surviving the merger as a wholly-owned subsidiary of New STERIS (the "Merger"), in exchange for ordinary shares of New STERIS, which was consummated simultaneous with and conditioned on New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law. At the effective time of the Merger, each STERIS common share was cancelled and converted into the right to receive one New STERIS ordinary share.
- [F2]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 4,995 ordinary shares of New STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F3]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 5,150 ordinary shares of New STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F4]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 6,727 ordinary shares of New STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F5]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 6,622 ordinary shares of New STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F6]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 5,936 ordinary shares of New STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
- [F7]At the effective time of the Merger, each STERIS career restricted stock unit was cancelled and converted to a New STERIS career restricted stock unit, subject to the same terms and conditions that were applicable to the original STERIS career restricted stock unit. These New STERIS career restricted stock units are fully vested and will be settled in New STERIS ordinary shares six months after the cessation of the Director's Board service.